Press release
RNA Therapeutics Market to Reach USD 29.6 Billion by 2034
RNA Therapeutics
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72419
The global RNA therapeutics market is expanding rapidly, driven by the success of mRNA vaccines, increasing investment in RNA-based drug development, and advancements in delivery technologies. Innovations in lipid nanoparticle (LNP) carriers, chemical modifications, and targeted delivery systems are enhancing stability, efficacy, and patient safety. The market spans oncology, rare genetic diseases, infectious diseases, and cardiovascular disorders, creating diverse opportunities for pharmaceutical and biotechnology companies.
Market Overview
• Market Size (2024): USD 8.3 billion
• Forecast (2034): USD 29.6 billion
• CAGR (2025-2034): 13.2%
Key Highlights:
• mRNA therapies, boosted by COVID-19 vaccine success, have accelerated market growth and adoption.
• Increasing prevalence of genetic disorders and cancer drives demand for targeted RNA therapeutics.
• Asia-Pacific is a high-growth region due to investment in biotech infrastructure, rising healthcare R&D, and expanding pharmaceutical manufacturing capabilities.
• Technological innovations in RNA delivery and stabilization are enabling broader therapeutic applications.
Segmentation Analysis
By Therapeutic Type:
• mRNA Therapeutics
o Includes vaccines for infectious diseases and oncology immunotherapies.
o Market growth driven by vaccine development and expanding cancer immunotherapy pipelines.
• siRNA Therapeutics
o Silences disease-causing genes by targeted mRNA degradation.
o Adopted in genetic disorders, liver diseases, and oncology.
• Antisense Oligonucleotides (ASOs)
o Bind to target mRNA to inhibit gene expression.
o Used for rare genetic disorders and neurological diseases.
• MicroRNA Therapeutics
o Modulates gene expression networks, with applications in oncology and cardiovascular diseases.
By Delivery Method:
• Lipid Nanoparticles (LNPs)
o Widely used for mRNA and siRNA delivery, improving stability and cellular uptake.
• Polymeric Carriers
o Provides controlled delivery for oligonucleotide therapeutics.
• Conjugated Delivery Systems
o Includes ligand-conjugated siRNA for targeted tissue delivery.
• Other Delivery Methods
o Viral vectors, exosomes, and other emerging delivery technologies.
By Application:
• Oncology
o RNA therapeutics targeting cancer-specific genes and immune modulation.
• Rare & Genetic Diseases
o Personalized RNA therapies for inherited disorders and neuromuscular diseases.
• Infectious Diseases
o Includes mRNA vaccines for viruses like COVID-19, influenza, and other emerging pathogens.
• Cardiovascular & Metabolic Disorders
o RNA therapies targeting cholesterol regulation, hypertension, and cardiomyopathies.
• Other Applications
o Neurological disorders, autoimmune diseases, and ophthalmic conditions.
Segmentation Summary:
mRNA therapies dominate, followed by siRNA and ASOs, with rapid growth in rare disease and oncology applications. Advancements in delivery technologies are critical for expanding the therapeutic potential of RNA-based drugs.
Explore Full Report here: https://exactitudeconsultancy.com/reports/72419/rna-therapeutics-market
Regional Analysis
North America
• Largest market due to strong R&D investment, advanced biotech infrastructure, and early adoption of RNA therapeutics and mRNA vaccines.
• The U.S. leads, with numerous clinical trials and commercialized RNA therapies.
Europe
• Germany, UK, France, and Switzerland are key markets, driven by government funding, biotech innovation, and adoption of advanced therapeutics.
• Strong focus on rare disease RNA therapeutics and oncology pipelines.
Asia-Pacific
• Fastest-growing region, led by China, Japan, and India.
• Growth fueled by biopharmaceutical investment, expanding clinical trials, and increased manufacturing capabilities for RNA drugs.
Latin America
• Brazil and Mexico are emerging markets for RNA vaccine distribution and clinical research collaborations.
Middle East & Africa
• Adoption increasing due to government investment in biotechnology, vaccine initiatives, and rising awareness of novel therapeutics.
Regional Summary:
North America dominates in revenue and adoption, while Asia-Pacific exhibits the highest growth potential, driven by investment, infrastructure, and clinical adoption of RNA-based therapeutics.
Market Dynamics
Key Growth Drivers:
• Increasing demand for personalized and targeted therapies.
• Success and adoption of mRNA vaccines for COVID-19 and other infectious diseases.
• Rising prevalence of oncology and rare genetic diseases.
• Technological advancements in RNA delivery, stabilization, and formulation.
• Expansion of clinical trials and government support for RNA-based therapeutics.
Key Challenges:
• High cost of RNA therapeutics and limited patient access in developing regions.
• Stability and storage requirements for RNA molecules, requiring cold chain logistics.
• Regulatory complexities for approval of novel RNA-based therapies.
Latest Trends:
• Increasing use of lipid nanoparticles and conjugated delivery systems for targeted RNA delivery.
• Development of next-generation mRNA vaccines and cancer immunotherapies.
• Strategic partnerships between biotech companies and CMOs for RNA manufacturing.
• Growth in personalized RNA therapies tailored to patient-specific genetic profiles.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72419
Competitor Analysis
Major Players in the Market:
• Moderna, Inc. - Leader in mRNA therapeutics and vaccines.
• BioNTech SE - Oncology and infectious disease-focused mRNA therapies.
• Alnylam Pharmaceuticals, Inc. - siRNA therapeutics for genetic and rare diseases.
• Ionis Pharmaceuticals, Inc. - ASO-based RNA therapeutics targeting neurological disorders.
• CureVac N.V. - mRNA vaccine development and RNA therapeutics pipeline.
• Translate Bio (Sanofi) - RNA therapies for respiratory and rare diseases.
• Arcturus Therapeutics - mRNA vaccine and delivery platform development.
Competitive Summary:
Moderna and BioNTech dominate mRNA therapeutics, while Alnylam and Ionis lead siRNA and ASO therapeutics. Companies focus on R&D investment, partnerships, and delivery technology innovations to expand RNA therapeutic applications across oncology, rare diseases, and infectious diseases.
Conclusion
The Global RNA Therapeutics Market, valued at USD 8.3 billion in 2024, is projected to reach USD 29.6 billion by 2034, growing at a CAGR of 13.2%.
Key Takeaways:
• mRNA therapies dominate, with rapid growth in siRNA, ASO, and microRNA therapeutics.
• North America leads in market share, while Asia-Pacific exhibits the fastest growth potential.
• Growth is driven by technological advancements, COVID-19 vaccine adoption, and increasing oncology and rare disease applications.
• Emerging trends include personalized RNA therapies, lipid nanoparticle delivery, and collaborations for scalable RNA manufacturing.
The RNA therapeutics market is poised for rapid expansion, revolutionizing precision medicine, infectious disease prevention, and targeted gene therapy, with innovations in delivery technology, formulation, and pipeline expansion shaping the next decade of global healthcare.
This report is also available in the following languages : Japanese (RNA治療薬市場), Korean (RNA 치료제 시장), Chinese (RNA治疗市场), French (Marché des thérapies à base d'ARN), German (Markt für RNA-Therapeutika), and Italian (Mercato della terapia dell'RNA), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/72419/rna-therapeutics-market#request-a-sample
Our More Reports:
Automatic Aseptic Sampling Market
https://exactitudeconsultancy.com/reports/73520/automatic-aseptic-sampling-market
Small Scale Bioreactors Market
https://exactitudeconsultancy.com/reports/73521/small-scale-bioreactors-market
Cell Migration and Cell Invasion Assay Market
https://exactitudeconsultancy.com/reports/73522/cell-migration-and-cell-invasion-assay-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Therapeutics Market to Reach USD 29.6 Billion by 2034 here
News-ID: 4199596 • Views: …
More Releases from Exactitude Consultancy
Allogeneic Cell Therapy Market to Reach USD 19.4 Billion by 2034
Allogeneic cell therapy involves the transplantation of cells derived from a donor to a recipient to treat various diseases, including cancer, autoimmune disorders, and degenerative conditions. Unlike autologous therapies, which use a patient's own cells, allogeneic therapies enable off-the-shelf availability, scalable manufacturing, and broader therapeutic applicability.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72421
The global allogeneic cell therapy market is expanding rapidly due to advancements in stem cell technologies,…
AAV Vector Market to Reach USD 4 Billion by 2034, Growing at 12% CAGR
Introduction
The rise of gene therapy has transformed the treatment landscape for genetic disorders, rare diseases, and oncology. At the center of this revolution are adeno-associated virus (AAV) vectors, which provide safe, efficient, and long-term gene delivery. With FDA and EMA approvals for multiple AAV-based therapies, coupled with expanding clinical pipelines, the AAV vector market is emerging as one of the fastest-growing sectors in biotechnology.
In 2024, the AAV vector market was…
Conjugation and Labeling Services Market to Reach USD 11.7 Billion by 2034
Conjugation and labeling services are specialized biopharmaceutical processes used in drug development and diagnostics, enabling targeted therapy, bioassays, and imaging applications. These services involve linking therapeutic molecules such as antibodies, proteins, or peptides to labels like radioisotopes, fluorophores, or drug payloads to enhance efficacy, tracking, and diagnostic capabilities.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72423
The global conjugation and labeling services market is witnessing strong growth due to the…
CRISPR Technologies White Space Analysis Market to Hit USD 20.4 Billion by 2034, …
Introduction
The rise of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has reshaped the future of genetic research and therapeutic development. Its precision, efficiency, and versatility make CRISPR the most promising tool for gene editing, agricultural biotechnology, and diagnostics.
Beyond current applications, white space analysis is essential for identifying untapped opportunities in new markets, technologies, and partnerships.
In 2024, the CRISPR technologies white spaces analysis market was valued at USD 8.5…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
